BCS1L
Mitochondrial chaperone BCS1
Also known as: BCS, BCS1_HUMAN, BJS, h-BCS, Hs.6719
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y276
- Gene
- BCS1L
- Ensembl
- ENSG00000074582
- Chromosome
- 2
- Canonical length
- 419 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Vesicles,Mid piece
OverviewNCBI Gene
This gene encodes a homolog of the S. cerevisiae bcs1 protein which is involved in the assembly of complex III of the mitochondrial respiratory chain. The encoded protein does not contain a mitochondrial targeting sequence but experimental studies confirm that it is imported into mitochondria. Mutations in this gene are associated with mitochondrial complex III deficiency and the GRACILE syndrome. Several alternatively spliced transcripts encoding two different isoforms have been described. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
419 residues, UniProt reviewed canonical sequence.
>Q9Y276|BCS1L
1 MPLSDFILAL KDNPYFGAGF GLVGVGTALA LARKGVQLGL VAFRRHYMIT LEVPARDRSY
61 AWLLSWLTRH STRTQHLSVE TSYLQHESGR ISTKFEFVPS PGNHFIWYRG KWIRVERSRE
121 MQMIDLQTGT PWESVTFTAL GTDRKVFFNI LEEARELALQ QEEGKTVMYT AVGSEWRPFG
181 YPRRRRPLNS VVLQQGLADR IVRDVQEFID NPKWYTDRGI PYRRGYLLYG PPGCGKSSFI
241 TALAGELEHS ICLLSLTDSS LSDDRLNHLL SVAPQQSLVL LEDVDAAFLS RDLAVENPVK
301 YQGLGRLTFS GLLNALDGVA STEARIVFMT TNHVDRLDPA LIRPGRVDLK EYVGYCSHWQ
361 LTQMFQRFYP GQAPSLAENF AEHVLRATNQ ISPAQVQGYF MLYKNDPVGA IHNAESLRRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BCS1L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 40 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 40 nTPM
- liver: 40 nTPM
- heart muscle: 39 nTPM
- kidney: 33 nTPM
- skeletal muscle: 31 nTPM
- adrenal gland: 29 nTPM
Single-cell type
- cardiomyocytes: 48 nCPM
- esophageal basal cells: 43 nCPM
- cytotrophoblasts: 38 nCPM
- esophageal suprabasal cells: 33 nCPM
- oocytes: 32 nCPM
- decidual stromal cells: 30 nCPM
Immune cell
- myeloid DC: 25 nTPM
- basophil: 20 nTPM
- plasmacytoid DC: 14 nTPM
- memory B-cell: 14 nTPM
- T-reg: 13 nTPM
- naive B-cell: 13 nTPM
Brain region
- white matter: 19 nTPM
- pons: 19 nTPM
- midbrain: 18 nTPM
- medulla oblongata: 17 nTPM
- cerebellum: 17 nTPM
- hypothalamus: 17 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about BCS1L.
Disease | AllUniProt
Conditions BCS1L is implicated in, by any mechanism.
- GRACILE syndrome (GRACILE) MIM:603358
- Mitochondrial complex III deficiency, nuclear type 1 (MC3DN1) MIM:124000
- Bjoernstad syndrome (BJS) MIM:262000
Disease | GeneticClinVar
140 pathogenic / likely-pathogenic of 603 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- GRACILE syndrome
- Pili torti-deafness syndrome
- Mitochondrial complex III deficiency nuclear type 1
- BCS1L-related disorder
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.24
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.62
- DepMap mean gene effect
- -0.38
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- mitochondrial respiratory chain complex I assembly
- mitochondrial respiratory chain complex III assembly
- mitochondrial respiratory chain complex IV assembly
- mitochondrion organization
- protein insertion into mitochondrial inner membrane from matrix
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- AAA+ ATPase domain
- ATPase, AAA-type, core
- ATPase, AAA-type, conserved site
- P-loop containing nucleoside triphosphate hydrolase
- ATPase family associated with various cellular activities (AAA)
- BCS1, N-terminal
- Mitochondrial chaperone BCS1 subfamily
- Mitochondrial chaperone BCS1-like, ATPase lid domain
- BCS1 N terminal
- Mitochondrial chaperone BCS1-like, ATPase lid domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BCS1L in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BCS1L as an antibody target. Whether an autoantibody or antibody against BCS1L could matter depends on whether native BCS1L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BCS1L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BCS1L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...